Anido Armando
SEC-identified person · CIK 1219866 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Scynexis INC SCYX | Director | filed 2019–2026 |
| Zynerba Pharmaceuticals, Inc. ZYNE | Director · Chairman & Chief Exec. Officer | filed 2015–2023 |
| Vaxart, Inc. VXRT | Director | filed 2015–2017 |
| Nupathe INC. path | Director · Chief Executive Officer | filed 2012–2014 |
| Adolor Corp adlr | Director | filed 2006–2011 |
| Auxilium Pharmaceuticals INC AUXL | Director · CEO & President | filed 2006–2011 |
| Medimmune INC /DE MEDI | EVP, Sales and Mktg | filed 2006–2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.